Evidence map›Paper›PMID 37744797›Full record

ArticleACS omega2023

Development of a Low-Cost Paper-Based Platform for Coffee Ring-Assisted SERS.

Anna S Rourke-Funderburg, Alec B Walter, Braden Carroll, Anita Mahadevan-Jansen, Andrea K Locke

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna S Rourke-FunderburgDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37240-0002, United States.ORCID https://orcid.org/0000-0002-7043-1370
Alec B WalterDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37240-0002, United States.
Braden CarrollVanderbilt Biophotonics Center, Vanderbilt University, Nashville, Tennessee 37240-0002, United States.
Anita Mahadevan-JansenDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37240-0002, United States.
Andrea K LockeDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37240-0002, United States.ORCID https://orcid.org/0000-0002-7357-9688

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need for highly sensitive, low-cost, and timely diagnostic technologies at the point of care is increasing. Surface-enhanced Raman spectroscopy (SERS) is a vibrational spectroscopic technique that is an advantageous technique to address this need, as it can rapidly detect analytes in small or dilute samples with improved sensitivity compared to conventional Raman spectroscopy. Despite the many advantages of SERS, one drawback of the technique is poor reproducibility due to variable interactions between nanoparticles and target analytes. To overcome this limitation, coupling SERS with the coffee ring effect has been implemented to concentrate and localize analyte-nanoparticle conjugates for improved signal reproducibility. However, current coffee ring platforms require laborious fabrication steps. Herein, we present a low-cost, two-step fabrication process for coffee ring-assisted SERS, utilizing wax-printed nitrocellulose paper. The platform was designed to produce a highly hydrophobic paper substrate that supports the coffee ring effect and tested using gold nanoparticles for SERS sensing. The nanoparticle concentration and solvent were varied to determine the effect of solution composition on ring formation and center clearance. The SERS signal was validated using 4-mercaptobenzoic acid (MBA) and tested with

Identifiers

PMID37744797
PMCPMC10515595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.